Locations Main Campus: Chesterfield, MO 63017   |   Locations
314-434-1500 314-434-1500   |   Contact Us

Multimedia Encyclopedia

BACK
TO
TOP
 
E-mail Form
Email Results

 
 
Print-Friendly
Bookmarks
bookmarks-menu

Multiple endocrine neoplasia (MEN) II

Sipple syndrome; MEN II; Pheochromocytoma - MEN II; Thyroid cancer - pheochromocytoma; Parathyroid cancer - pheochromocytoma

 

Multiple endocrine neoplasia, type II (MEN II) is a disorder passed down through families in which one or more of the endocrine glands are overactive or form a tumor. Endocrine glands most commonly involved include:

  • Adrenal gland (about half the time)
  • Parathyroid gland (20% of the time)
  • Thyroid gland (almost all of the time)

Multiple endocrine neoplasia ( MEN I ) is a related condition.

Causes

 

The cause of MEN II is a defect in a gene called RET. This defect causes many tumors to appear in the same person, but not necessarily at the same time.

Involvement of the adrenal gland is most often with a tumor called a pheochromocytoma .

Involvement of the thyroid gland is most often with a tumor called medullary carcinoma of the thyroid .

Tumors in the thyroid, adrenal, or parathyroid glands may occur years apart.

The disorder may occur at any age, and affects men and women equally. The main risk factor is a family history of MEN II.

There are 2 subtypes of MEN II. They are MEN IIa and IIb. MEN IIb is less common.

 

Symptoms

 

The symptoms may vary. However, they are similar to those of:

  • Medullary carcinoma of the thyroid
  • Pheochromocytoma
  • Parathyroid adenoma
  • Parathyroid hyperplasia

 

Exams and Tests

 

To diagnose this condition, the health care provider looks for a mutation in the RET gene. This can be done with a blood test. Additional tests are done to determine which hormones are being overproduced.

A physical exam may reveal:

  • Enlarged lymph nodes in the neck
  • Fever
  • High blood pressure
  • Rapid heart rate
  • Thyroid nodules

Imaging tests used to identify tumors may include:

  • Abdominal CT scan
  • Imaging of the kidneys or ureters
  • MIBG scintiscan
  • MRI of abdomen
  • Thyroid scan
  • Ultrasound of the thyroid

Blood tests are used to see how well certain glands in the body are working. They may include:

  • Calcitonin level
  • Blood alkaline phosphatase
  • Blood calcium
  • Blood parathyroid hormone level
  • Blood phosphorus
  • Urine catecholamines
  • Urine metanephrine

Other tests or procedures that may be done include:

  • Adrenal biopsy
  • Electrocardiogram ( ECG )
  • Thyroid biopsy
  • Parathyroid biopsy

 

Treatment

 

Surgery is needed to remove a pheochromocytoma, which can be life-threatening due to the hormones it makes.

For medullary carcinoma of the thyroid, the thyroid gland and surrounding lymph nodes must be totally removed. Thyroid hormone replacement therapy is given after surgery.

If a child is known to carry the RET gene mutation, surgery to remove the thyroid before it becomes cancerous is considered. This should be discussed with a physician who is very familiar with this condition. It would be done at an early age (before age 5) in people with known MEN IIa, and before age 6 months in people with MEN IIb.

 

Outlook (Prognosis)

 

Pheochromocytoma is most often not cancerous (benign). Medullary carcinoma of the thyroid is a very aggressive and potentially fatal cancer, but early diagnosis and surgery can often lead to a cure. Surgery does not cure the underlying MEN II.

 

Possible Complications

 

The spread of cancerous cells is a possible complication.

 

When to Contact a Medical Professional

 

Call your health care provider if you notice symptoms of MEN II or if someone in your family receives such a diagnosis.

 

Prevention

 

Screening close relatives of people with MEN II may lead to early detection of the syndrome and related cancers. This may allow for steps to prevent complications.

 

 

Open References

References

National Comprehensive Cancer Network. Clinical practice guidelines in oncology: neuroendocrine tumors. National Comprehensive Cancer Network; 2014. Updated May 25, 2016. Version 1.2015. www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf . Accessed April 6, 2016.

Nieman LK, Spiegel AM. Polyglandular disorders. In: Goldman L, Schafer AI, eds. Goldman's Cecil Medicine . 25th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 231.

Tacon LJ, Learoyd DL, Robinson BG. Multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. In: Jameson JL, De Groot LJ, de Kretser DM, et al, eds. Endocrinology: Adult and Pediatric . 7th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 149.

 
  • Endocrine glands

    Endocrine glands - illustration

    Endocrine glands release hormones (chemical messengers) into the bloodstream to be transported to various organs and tissues throughout the body. For instance, the pancreas secretes insulin, which allows the body to regulate levels of sugar in the blood. The thyroid gets instructions from the pituitary to secrete hormones which determine the pace of chemical activity in the body (the more hormone in the bloodstream, the faster the chemical activity; the less hormone, the slower the activity).

    Endocrine glands

    illustration

    • Endocrine glands

      Endocrine glands - illustration

      Endocrine glands release hormones (chemical messengers) into the bloodstream to be transported to various organs and tissues throughout the body. For instance, the pancreas secretes insulin, which allows the body to regulate levels of sugar in the blood. The thyroid gets instructions from the pituitary to secrete hormones which determine the pace of chemical activity in the body (the more hormone in the bloodstream, the faster the chemical activity; the less hormone, the slower the activity).

      Endocrine glands

      illustration

    A Closer Look

     

      Tests for Multiple endocrine neoplasia (MEN) II

       
         

        Review Date: 3/16/2016

        Reviewed By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.

        The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

         
         
         

         

         

        A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.



        Content is best viewed in IE9 or above, Firefox and Google Chrome browser.